populations.
reported so far in the particular case of natural killer-type malignant cells, which express FasL on their surface and release it in the circulation, thereby contributing to specific Introduction tissue alterations in those patients. 21 To our knowledge, a comprehensive analysis of the status of FasL expression in Fas/CD95 and its ligand (FasL) are respectively members of fresh human lymphoma tissues has not yet been reported. One two superfamilies of complementary receptors and ligands may hypothesize that FasL production by the malignant cell which play important roles in the regulation of the immune component might result in the elimination of Fas-positive system (see Ref. 1 for review). Fas, also called APO-1 2,3 is a reactive T cells, and could potentially favor tumor growth. type I membrane protein of 45 kilodaltons (kDa) belonging to Another question to address is the putative interaction the tumor necrosis factor receptor (TNFR) superfamily. 4 between reactive T cells expressing FasL and neoplastic B Among these receptors, Fas and the p55 TNFR only share a cells expressing Fas, which might antagonize tumor develop-70 aminoacid intracellular 'death domain' which transduces ment. Because of the role of Fas in receiving and transducing signals for cell death. 4 Fas mediates apoptosis when crossthe FasL-induced apoptotic signal, the respective sensitivities linked with agonistic anti-Fas antibodies. 5, 6 FasL is a 40 kDa of B cell and T cell populations from lymphoma tissues to Fastype II membrane protein expressed as a membrane-bound induced apoptosis were also investigated. This report shows form, which is then proteolytically processed into a soluble that FasL is expressed in both the neoplastic and reactive cell cytokine retaining biological activity. [7] [8] [9] [10] population from a significant proportion of lymphoma cases, There is accumulating evidence from Ipr and gld mice modand that Fas-positive malignant B cells are less sensitive to els that Fas/FasL-mediated apoptosis is a crucial regulatory Fas-mediated apoptosis than intratumoral Fas-positive reactive process which limits immune response and provides a safe-T cells. guard against emergence of auto-reactive lymphocytes. [11] [12] [13] [14] Ipr mutant mice harbor either an early transposable element or a mutation in the Fas gene, which either severely reduce Materials and methods the expression of a full size Fas transcript, or abolish its ability Tissue sampling and study design and Fas mRNAs using reverse transcriptase-polymerase chain CD21, CD22, CD23, CD24, and immunoglobulin light chains, ␦, , ␥, and ␣ immunoglobulin heavy chains), T cells (CD2, CD3, CD4, CD5, CD7, CD8) and ReedSternberg/activated cells (CD30). For double-color flow cyto-CAT GAA CCC ATG TTT GCA-3′ (nucleotide positions: 2118-2142)) for Fas. Oligonucleotide probes were labeled with a 3′ metric analysis, cells were labeled with fluorescently tagged mAbs recognizing the cell surface molecules, Fas, FasL, CD3 tailing kit (Boehringer Mannheim) according to the supplier's recommendations. After hybridization, filters were washed and CD19 for 30 min at 4°C. They were then washed and fixed with 1% paraformaldehyde in PBS before FACS analysis. twice for 10 min at room temperature in 2 × SSC containing 0.1% SDS, and twice for 10 min at 55°C in 0.1 × SSC contain-A negative control labeling using an isotype-matched FITCconjugated antibody was simultaneously performed. ing 0.1% SDS, then underwent revelation using a chemiluminescence detection kit (Boehringer Mannheim).
Western blot (WB) analysis Purification of B and T cells from fresh lymphoma tissues
Frozen tissues crushed in liquid nitrogen, or cell suspensions, were thrown in lysis buffer (10 mM Tris HCl buffer pH 7.4, B cells and T cells from fresh tissue samples, obtained by teascontaining 1% SDS and 1 mM sodium vanadate) and then ing, were separated with magnetic beads (Immunotech) conjuheated in a microwave oven for 10-15 s. Proteins in lysates gated with anti-CD19 and anti-CD3 mouse IgG mAbs. Purwere separated by 7.5% SDS-PAGE and transferred to Immobified populations were then submitted to WB, FACS analysis ilon-P membranes (Millipore, Medford, MA, USA) as recand/or apoptotic tests. Isolated B cells were uniformly Ͼ90% ommended by the manufacturer. FasL was detected with a CD20 + and Ͻ10% CD2 + . Isolated T cells were Ͼ90% CD2 + mouse IgG3 mAb, raised against a 18 kDa polypeptide correand Ͻ10% CD19 + . The monoclonality of isolated malignant sponding to amino acids 116-277 of human FasL B cell populations was checked by the exclusive detection of (Transduction Laboratories, Lexington, KY, USA). Immunoreor light chains (Dakopatts). Sensitivity of purified cells to active material was visualized by enhanced chemilumiFas-mediated apoptosis was determined as described below. nescence (Amersham). Jurkat cells stimulated with phytohemagglutinin A (PHA, 10 g/ml, Sigma, St Louis, MO, USA) served as a positive control. Unstimulated Jurkat cells were used as a negative control. Immunotech) in case 6631; the results of both methods were found to be correlated (data not shown) as previously demon-(UB2 clone, Immunotech) for 30 min at 4°C. Cells were then washed in phosphate-buffered saline (PBS), fixed with 1% parstrated. 26 Negative controls were performed by 7A6 detection on cell populations incubated without 7C11. The relative aformaldehyde and analyzed on a FACS Star IV flow cytometer (Becton Dickinson, San Jose, CA, USA).
Assessment of Fas-mediated apoptosis
sensitivity/resistance to 7C11-induced cell death of the neoplastic cell populations in each sample was defined by comFor detection of surface FasL expression, cells were incubated for 45 min with affinity-purified rabbit anti-human FasL parison with the reactive cell component isolated from the same tissue sample. polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz,
Results
FasL, as examplified in Figure 3 . Fas expression was detected in parallel with FasL expression in most cases (Table 2 ).
FasL and Fas mRNAs are frequently coexpressed in lymphoma tissues WB analysis detects the FasL protein in both neoplastic and reactive cell populations
The results of RT-PCR experiments are illustrated in Figure 1 , and summarized in Table 1 . RT-PCR analysis was repeated at least twice for each sample. The relative differences in ampliTo confirm and extend the RT-PCR and flow cytometry data, WB analysis was performed using a different anti-FasL mAb. fication levels were reproducibly observed in the various experiments, indicating that they reflect differences in mRNA
In lysates from total lymphoma tissues, the expected 40 kDa band was detected in the FACS-positive samples (examplified concentrations, rather than random variations. The relative levels of FasL RNA expression could thus be estimated, after in Figure 4 ), whereas FACS-negative samples gave no signal ( Table 2) . WB was also performed on lysates of B and T cell normalization with control RT-PCR for actin, and ranged from + (weak signal) to +++ (strong signal).
fractions purified from total lymphoma populations. FasL protein expression was detected in purified B cells from B-NHL A strong expression of FasL mRNA was observed in activated Jurkat cells, whereas non-activated cells were negative cases as well as in the reactive T cell populations from the same samples ( Figure 4 and Table 2 ). In one HD case, FasL (Figure 2 ). Positive FasL bands were clearly detectable in 38 out of the 63 lymphoma specimens. Positive cases were disexpression was observed in both the CD30 + and CD3 + cell subpopulations (Figure 4) . tributed as follows: 7/15 HD cases, 22/34 B cell lymphoma cases and 8/14 T cell NHL cases. The levels of expression, as judged by band intensity, were not correlated with a particular lymphoma subtype ( Figure 1 and Table 1 Apoptosis was evaluated by the immunodetection of the antigen 7A6, which defines a novel epitope on the mitochondrial sFas mRNA. Fas and FasL were often co-expressed (Table 1) , except for 10 cases which only expressed FasL, and five cases membrane, that appears to be exposed on cells undergoing apoptosis. 26 The anti-7A6 positivity on permeabilized cells is which only expressed Fas.
strictly correlated with the apoptosis induced in PBL and in lymphoid cell lines. 26 Fresh neoplastic B cells from the four B cell tumors tested were significantly less sensitive to Fas-FACS analysis detects FasL and Fas proteins in both neoplastic and reactive cell populations mediated apoptosis than the reactive T cells isolated from the corresponding lymphoma tissues ( Figure 5 and Table 3 ). Higher concentrations of 7C11 and/or longer incubation perThe 16 lymphoma cases analyzed for surface FasL expression showed variable percentages of positive populations, as iods were indeed not sufficient to obtain similar rates of cell death in the neoplastic B cells and in the reactive T cells detailed in Tables 2 and 3 . FACS detection of surface FasL correlated well with the results of RT-PCR analysis of lym-( Table 3 ). The relative resistance of the different cell populations was not strictly related to Fas expression levels phoma samples and control Jurkat cells (Figure 2 ). Two cases of lymphocytic NHL and one case of follicular NHL were con-( Table 3 ). The susceptibility of malignant T cells to 7C11-induced apoptosis appeared heterogeneous in the two T cell sidered as negative. In the other cases, bright FasL staining was observed in 31% to up to 75% of the total cell population lymphomas tested. Malignant T cells from one case were almost as sensitive as control Jurkat cells. In the other case, ( Table 2) . Dual-color flow cytometric analysis showed that FasL was expressed by T cells in B cell NHLs, HD and T cell the neoplastic T cell population displayed slightly higher apoptotic rates than the reactive/residual B cell population NHLs (Figure 3) . A significant percentage of B cells in various histologic subtypes of B cell NHLs also stained positively with (Table 3) .
Discussion
The Fas/FasL apoptotic pathway was shown to play a key role in the immune system by triggering the activation-induced suicide of T cells (for review see Ref. 27) . Resting T cells normally express low levels of Fas; this expression, however, increases significantly within hours of engagement of their antigen receptor. 2, 3 Several days after the initial activation, this pathway becomes effective, and T cells undergo apoptosis via cross-linking of the FasL concomitantly upregulated in acti- respectively) to +++, as in lanes 10, 12 and 14 (corresponding to one HD and two PTL samples, respectively).
In the present report we show that FasL is expressed by both neoplastic and reactive cell components in the majority of appears unlikely; we could not detect sFas encoding transcripts in any of the lymphoma samples analyzed. We determhuman lymphoma tissues, and that FasL can be coexpressed with Fas on malignant cells. Thus, intratumoral triggering of ined the levels of Bcl-2 expression by RT-PCR in these NHL cases, and found no correlation with the profiles of Fas/FasL Fas via FasL probably occurs in lymphoma cells in vivo. We also report here the application of a new method for monitorexpression, ie coexpression was not associated with high levels of Bcl-2 (data not shown). However, this does not rule out ing apoptosis in fresh cells isolated from human tissues, and show that malignant and reactive cells from B cell NHLs the possibility of an upregulation of the Bcl-2 protein. Similarly, we cannot exclude the influence of another anti-apopdisplay a different sensitivity to Fas-mediated apoptosis.
It has been previously demonstrated that the level of Fas totic factor downstream of Fas, like Bcl-xL, which we previously found to be hyperexpressed in human lymphomas. 36 expression in lymphoid malignancies is not always correlated with anti-Fas-mediated cell death. 34, 35 We extend these earlier Another possibility could be that lymphoma cells are not sensitive to Fas triggering because of interfering activation sigresults by showing that FasL expressing B cells from lymphoma tissues are much more resistant to Fas triggering than nals. The activation state of B cells is indeed critical for their sensitivity to Fas. 37 Under certain circumstances, Fas was the corresponding intratumoral reactive T cells. This difference in apoptosis susceptibility is likely to explain why the shown to deliver a positive activation signal, resulting in cell proliferation. 38 One can also speculate that Fas/FasL interacFas/FasL pathway does not allow for an effective autocrine and/or paracrine regulation of tumor growth. The tion is not an impediment for the development of malignant lymphoma because the primary structure of Fas is altered, thus mechanism(s) responsible for insensitivity to Fas-mediated killing remain unclear. The possibility that the effects of FasL rendering it inactive. Fas structural defects were identified in some Fas-resistant cell lines which harbor a truncated Fas might be neutralized by the production of soluble Fas (sFas) molecule. 39 None the less, our previous search for rearrangeunlikely, as a recent description of the human auto-immune lymphoproliferative syndrome showed that such mutations ments and/or deletions of the Fas gene in a large series of fresh lymphoma samples did not reveal a frequent occurrence of either result in lymphoid hyperplasia in childhood, or remain silent. 15, 16 such abnormalities. 40 The presence of point mutations of the Fas gene in lymphomas cannot be excluded, but appears
What might be the relevance of in vivo expression for FasL 
